1. Home
  2. VBIO vs NIKI Comparison

VBIO vs NIKI Comparison

Compare VBIO & NIKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valion Bio Inc. Common Stock

VBIO

Valion Bio Inc. Common Stock

N/A

Current Price

$0.51

Market Cap

1.3M

Sector

Health Care

ML Signal

N/A

Logo Niki BioSolutions Inc. Common Stock

NIKI

Niki BioSolutions Inc. Common Stock

N/A

Current Price

$1.57

Market Cap

1.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VBIO
NIKI
Founded
2016
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3M
1.5M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
VBIO
NIKI
Price
$0.51
$1.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 248.6K
18.1K
Earning Date
12-01-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $780,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$48.88
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.12
$1.42
52 Week High
$812.50
$10.39

Technical Indicators

Market Signals
Indicator
VBIO
NIKI
Relative Strength Index (RSI) 22.39 29.27
Support Level $0.47 $1.42
Resistance Level $4.39 $2.14
Average True Range (ATR) 0.05 0.17
MACD 0.60 0.11
Stochastic Oscillator 27.92 17.71

Price Performance

Historical Comparison
VBIO
NIKI

About VBIO Valion Bio Inc. Common Stock

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

About NIKI Niki BioSolutions Inc. Common Stock

Niki BioSolutions Inc is a clinical-stage life sciences company focused on unmet medical needs and providing genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations. Its activities include the development and application of proprietary technologies to support precision medicine across therapeutic areas including brain health and oncology. The company also collaborates with academic centers, disease foundations, and biopharmaceutical companies.

Share on Social Networks: